Merck in Push to Double Medical Engineering Production in USA by 2023
Gardasil has proven to be in great demand - a human papillomavirus (HPV) vaccine made by Merck & Co that has been a game-changer in terms of prevention. However, there have been issues with supply over the past few years, especially in 2018 and 2019. As a result, Merck has now revealed that it invested $1 billion to tackle the issues of supply when they arose - and the business is now reaping the rewards of that investment in terms...
View full press release